Vijay Iyengar

Vijay Iyengar is a highly accomplished professional with a strong educational background and extensive experience in the healthcare industry.

He holds a Bachelor of Science degree from Stanford University and a Doctor of Medicine in Medicine from Harvard Medical School, showcasing his commitment to academia and medicine.

Vijay has held key leadership positions in various prestigious organizations, including his current role as the Executive Vice President of Global Product Strategy, BD and L, and Strategic Planning at Incyte, a testament to his strategic acumen and business acumen.

Prior to his current role, he served as the President at Genoptix Medical Laboratory, a Novartis company, where he showcased his leadership skills and industry expertise.

His tenure at Novartis was marked by progressive roles, including Vice President of Rare Diseases Franchise Head, Oncology General Manager, Global Brand Executive Director, and Global Brand Director in the oncology sector, showcasing his versatile skill set and industry knowledge.

Before his time at Novartis, Vijay Iyengar worked as an Engagement Manager at McKinsey & Company, further enhancing his strategic consulting skills and business acumen.

Vijay Iyengar's career trajectory highlights his expertise in strategic planning, leadership, healthcare management, and pharmaceuticals, making him a respected figure in the industry.